Zobrazeno 1 - 10
of 258
pro vyhledávání: ''
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundAtrial fibrillation (AF) and breast cancer pose significant risks to human health. The reasons behind the concurrent occurrence of AF and breast cancer remain unclear, leading to complex treatment approaches. Mendelian Randomization (MR) an
Externí odkaz:
https://doaj.org/article/8dc88418c36f4c3ab78d6302ae370c50
Autor:
Huiming Huang, Jinxin Xie, Fei Wang, Shungang Jiao, Xingxing Li, Longyan Wang, Dongxiao Liu, Chaochao Wang, Xuejiao Wei, Peng Tan, Pengfei Tu, Jun Li, Zhongdong Hu
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundBreast cancer (BC) is one of the most frequently observed malignancies globally, yet drug development for BC has been encountering escalating challenges. Commiphora myrrha is derived from the dried resin of C. myrrha (T. Nees) Engl., and is
Externí odkaz:
https://doaj.org/article/5a28e389b8e14d0495c8899fd47b206c
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundBreast cancer lung metastasis occurs at a high rate and at an early stage, and is the leading cause of death in breast cancer patients. The aim of this study was to investigate the effect of Ru’ai Shuhou Recipe (RSR) intervention on the o
Externí odkaz:
https://doaj.org/article/72ac00f8982e44e5becfbef9fded5053
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/a1923120593843f69e7646d8d34fd8cf
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundThis study aimed to assess the cost-effectiveness of combining utidelone with capecitabine, compared to capecitabine monotherapy, for the treatment of anthracycline- and taxane-refractory metastatic breast cancer within the Chinese healthca
Externí odkaz:
https://doaj.org/article/dee1e324d4a9483eaf9d1fcfe77470ff
Autor:
Yalan Yan, Sijie Li, Lanqian Su, Xinrui Tang, Xiaoyan Chen, Xiang Gu, Guanhu Yang, Hao Chi, Shangke Huang
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Breast cancer, due to resistance to standard therapies such as endocrine therapy, anti-HER2 therapy and chemotherapy, continues to pose a major health challenge. A growing body of research emphasizes the heterogeneity and plasticity of metabolism in
Externí odkaz:
https://doaj.org/article/6c38e4fa446f4a4c85e9ddcd8b7749fe
Autor:
Sukanya B. Jadhav, Michaela Vondrackova, Petra Potomova, Cristian Sandoval-Acuña, Jana Smigova, Kristyna Klanicova, Daniel Rosel, Jan Brabek, Jan Stursa, Lukas Werner, Jaroslav Truksa
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Multiple studies indicate that iron chelators enhance their anti-cancer properties by inducing NDRG1, a known tumor and metastasis suppressor. However, the exact role of NDRG1 remains controversial, as newer studies have shown that NDRG1 can also act
Externí odkaz:
https://doaj.org/article/babf7f9ee7ce45d2aa4ee3ab2d7ec896
Autor:
Frontiers Production Office
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/09a3639dbb854124948ce469bf13e324
Autor:
Deena Elsori, Pratibha Pandey, Seema Ramniwas, Rahul Kumar, Sorabh Lakhanpal, Safia Obaidur Rab, Samra Siddiqui, Ajay Singh, Mohd Saeed, Fahad Khan
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
The bioactive compounds present in citrus fruits are gaining broader acceptance in oncology. Numerous studies have deciphered naringenin’s antioxidant and anticancer potential in human and animal studies. Naringenin (NGE) potentially suppresses can
Externí odkaz:
https://doaj.org/article/1dc2e58459a64791bb71e2fa1c2a6a12
Autor:
Nusrat Jan, Shazia Sofi, Adel Abo Mansoor, Adil Abdelrahim, Irshad Ahmad, Abdullah Almilabairy, Fuzail Ahmad, Manzoor Ahmad Mir
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionThe members retinoic acid receptors (RARs) (α, β, and γ) and retinoid X receptors (RXRs) (α, β, and γ) belong to the retinoid receptor family. They regulate the biological action of classical retinoids through nuclear retinoid recep
Externí odkaz:
https://doaj.org/article/cce449628de94fa5926ed4c77949c867